PAMS
Pictet Asset Management (Switzerland)’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $385M | Buy |
4,991,061
+739,901
| +17% | +$57M | 0.46% | 51 |
|
|
2023
Q1 | $353M | Buy |
4,251,160
+931,921
| +28% | +$77.3M | 0.44% | 54 |
|
|
2022
Q4 | $285M | Buy |
3,319,239
+39,948
| +1% | +$3.43M | 0.41% | 58 |
|
|
2022
Q3 | $202M | Buy |
3,279,291
+1,067,966
| +48% | +$65.9M | 0.3% | 96 |
|
|
2022
Q2 | $137M | Buy |
2,211,325
+60,050
| +3% | +$3.71M | 0.19% | 155 |
|
|
2022
Q1 | $128M | Sell |
2,151,275
-586,695
| -21% | -$34.9M | 0.14% | 193 |
|
|
2021
Q4 | $199M | Sell |
2,737,970
-1,644,688
| -38% | -$119M | 0.2% | 151 |
|
|
2021
Q3 | $306M | Buy |
+4,382,658
| New | +$306M | 0.34% | 77 |
|